BRIEF

on BASTIDE (EPA:BLC)

Sustained growth for Bastide in the first half of 2024-2025

Stock price chart of BASTIDE (EPA:BLC) showing fluctuations.

The Bastide Group recorded organic growth of 8.4% in the first half of the 2024-2025 financial year. Half-yearly revenue reached €275.2 million, marked by a significant increase in home healthcare services (+10.2%). The “Home Care” segment returned to growth (+3.6%).

High-tech activities, such as Respiratory and Nutrition, continued to boost performance. The Respiratory activity generated €100.9 million, an increase of 12.8%. In-store sales also increased by 5.6% despite the reorganization of the network.

Confident, the Group maintains its annual turnover target of at least €560 million, supported by a targeted operating margin of 8.7%. Continued debt reduction remains a strategic priority.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BASTIDE news